SEC Form 4 · accession 0001628280-26-057813
Veradermics, Inc · MANE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Reid Alexander Waldman
Officer — Chief Executive Officer · Director
Period of report
Aug 17, 2026
Accepted (ET)
Aug 18, 2026 · 9:04 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001827635
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 17, 2026 | M | 3,452 | $12.19 | A | 238,324 | D | |
| Common StockF1 | Aug 17, 2026 | S | 11,527 | $106.72 | D | 226,797 | D | |
| Common StockF2 | Aug 17, 2026 | S | 25,234 | $107.53 | D | 201,563 | D | |
| Common StockF3 | Aug 17, 2026 | S | 27,490 | $108.45 | D | 174,073 | D | |
| Common StockF4 | Aug 17, 2026 | S | 3,000 | $109.38 | D | 171,073 | D | |
| Common Stock | Aug 17, 2026 | S | 249 | $111.28 | D | 170,824 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F5 | $12.19 | Aug 17, 2026 | M | 3,452 | D | — | Dec 12, 2026 | Common Stock | 3,452 | 0 | D |
Explanation of responses
- F1The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $106.07 to $107.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F2The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $107.00 to $108.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F3The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $108.00 to $108.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F4The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $109.02 to $109.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F5This option is fully vested and exercisable as of the date hereof.